Successful Pregnancy after Intervention for Spindle-Cell Embryonal Rhabdomyosarcoma: A Case Report

J Pediatr Adolesc Gynecol. 2020 Oct;33(5):613-615. doi: 10.1016/j.jpag.2020.03.004. Epub 2020 Mar 26.

Abstract

Background: Embryonal rhabdomyosarcoma, the most common soft tissue malignancy in childhood, is treated with surgery and chemotherapy. Because of the young age at the time of presentation, a discussion of future reproduction is appropriate and conservative management should be considered. We present a case of embryonal rhabdomyosarcoma that was successfully and conservatively managed with chemotherapy, allowing for future pregnancies.

Case: A 17-year-old nulliparous woman with embryonal rhabdomyosarcoma underwent 6 cycles of chemotherapy with adriamycin, dacarbazine, cyclophosphamide, and vincristine, resulting in radiographic resolution of the disease. She was able to conceive without medical intervention and to have successful vaginal deliveries.

Summary and conclusion: The standard of care for embryonal rhabdomyosarcoma is surgery and chemotherapy; however, conservative management should be considered when preservation of fertility is a goal.

Keywords: Embryonal rhabdomyosarcoma; Fertility preservation; Oncofertility; Pediatrics.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / administration & dosage*
  • Doxorubicin / administration & dosage*
  • Female
  • Fertility Preservation / methods
  • Humans
  • Pregnancy
  • Rhabdomyosarcoma, Embryonal / drug therapy*
  • Rhabdomyosarcoma, Embryonal / pathology
  • Uterine Cervical Neoplasms / drug therapy*
  • Uterine Cervical Neoplasms / pathology
  • Vincristine / administration & dosage*

Substances

  • Vincristine
  • Doxorubicin
  • Cyclophosphamide